REG - Integrated Diag Hdgs - Total Voting Rights

Integrated Diagnostics HoldingsAnnouncement

01/10/2024 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241001:nRSA3326Ga&default-theme=true

RNS Number : 3326G  Integrated Diagnostics Holdings PLC  01 October 2024

 

Integrated Diagnostics Holdings plc

 

(the 'Company')

 

TOTAL VOTING RIGHTS

 

 

1 October 2024

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and
Transparency Rule 5.6.1R, the Company hereby notifies the market of the
following:

 

The Company's issued share capital as at 30 September 2024 consisted of
600,000,000 shares of US$0.25 each ('Ordinary Shares'), of which 18,673,728
Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is
581,326,272. This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the Company under the
Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

 

Integrated Diagnostics Holdings plc

Tarek Yehia

Investor Relations Director

T: +20 (0)2 3332 1126 | M: +20 10 6882 6678 | tarek.yehia@idhcorp.com
(mailto:tarek.yehia@idhcorp.com)

 

Company Secretary

Company Matters

IDHLondon@linkgroup.co.uk (mailto:IDHLondon@linkgroup.co.uk)

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVREAKNEDLXLEFA